Deletion of VAI and VAII RNA Genes in the Design of Oncolytic Adenoviruses
- 1 September 2006
- journal article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 17 (9) , 929-940
- https://doi.org/10.1089/hum.2006.17.929
Abstract
Deletion of viral functions that can be complemented by the specific phenotype of tumor cells is a common strategy to design oncolytic viruses. For example, enhanced mRNA cytoplasmic export in tumor cells phenocopies the adenovirus E1B-55K function and renders mutants of this protein tumor selective. Also, an activated RB pathway complements specific E1A functions that can be deleted to produce oncolytic viruses. In this paper we demonstrate that an adenoviral mutant deleted in virus-associated I (VAI) and VAII RNAs (Ad-VAdel) has oncotropism characterized by 100-fold replication deficiency compared with wild-type adenovirus in normal cells and an unaffected ability to replicate and kill different types of tumor cells. This mutant also displays active antitumoral activity in vivo. In contrast, this oncotropism is less evident in a mutant expressing an inactive form of VAI (Adsub719) because VAII RNA expression is upregulated. The mRNA translation promoted by VA RNA genes can be phenocopied in tumor cells with the activation of signal transduction pathways, such as the Ras pathway.Keywords
This publication has 40 references indexed in Scilit:
- Oncolysis of pancreatic tumour cells by a γ34.5-deleted HSV-1 does not rely upon Ras-activation, but on the PI 3-kinase pathwayGene Therapy, 2006
- Adenovirus-Induced Extracellular Signal-Regulated Kinase Phosphorylation during the Late Phase of Infection Enhances Viral Protein Levels and Virus ProgenyCancer Research, 2006
- Activating Ras Mutations Fail to Ensure Efficient Replication of Adenovirus Mutants Lacking VA-RNACell Cycle, 2005
- Virus-Associated RNA I–Deleted Adenovirus, a Potential Oncolytic Agent Targeting EBV-Associated TumorsCancer Research, 2005
- Vesicular stomatitis virusCancer Cell, 2003
- Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2003
- PKR; a sentinel kinase for cellular stressOncogene, 1999
- Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cancer cellsOncogene, 1998
- Anti-interferon activity of adenovirus-2-encoded VAI and VAII RNAs in translation in cultured human cellsVirus Research, 1996
- Adenovirus VAI RNA facilitates the initiation of translation in virus-infected cellsCell, 1984